FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950876717> ?p ?o ?g. }

• W2950876717 endingPage "e0217597" @default.
• W2950876717 startingPage "e0217597" @default.
• W2950876717 abstract "Drug-resistant tuberculosis (TB), especially multidrug-resistant TB (MDR-TB), poses a threat to public health. While standard surveillance focuses on Rifampicin and/or Isoniazid resistance, little is known about other resistance patterns. This study aims to identify predominant drug resistance (DR) patterns in Germany and risk factors associated with them in order to inform diagnostic and treatment strategies.Case-based TB surveillance data notified in Germany from 2008-2017 were utilized to investigate DR and MDR-TB patterns for Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E), and Streptomycin (S). Predominant patterns were further analyzed stratified by sex, age, country of birth, prior TB, and disease site. Multivariable logistic regression was conducted to determine risk factors associated with any resistance, MDR-TB, and complete HRZES resistance.26,228 cases with complete DST results were included in the study, among which 3,324 cases had any DR (12.7%). Four patterns were predominant, representing about ¾ of all cases with any resistance (S: 814 [3.1%]; H: 768 [2.9%]; HS: 552 [2.1%]; Z: 412 [1.6%]). High proportions of S and H resistances were found among both German and foreign-born populations, especially those born in Eastern Europe, and were unexpectedly high among children (H: 4.3%; S: 4.6%). Foreign-born cases had significantly higher proportion of any resistance (16.0%) and MDR-TB (3.3%) compared to German-born cases (8.3% and 0.6%). Of 556 MDR-TB cases, 39.2% showed complete HRZES resistance. Logistic regression revealed having prior TB and being foreign-born as consistently strong risk factors for any DR, MDR-TB, and complete HRZES resistance.DR patterns observed in Germany, particularly for MDR-TB were more complex than expected, highlighting the fact that detailed drug-testing results are crucial before incorporating HRZES drugs in MDR-TB treatment. Furthermore, the relatively high rate of H-resistance in Germany provides strong rationale against the use of only H-based preventive therapy for LTBI." @default.
• W2950876717 created "2019-06-27" @default.
• W2950876717 creator A5008945022 @default.
• W2950876717 creator A5034425770 @default.
• W2950876717 creator A5034880637 @default.
• W2950876717 creator A5042290811 @default.
• W2950876717 creator A5052727163 @default.
• W2950876717 creator A5068301606 @default.
• W2950876717 date "2019-06-12" @default.
• W2950876717 modified "2023-10-11" @default.
• W2950876717 title "First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017" @default.
• W2950876717 cites W103599567 @default.
• W2950876717 cites W132398878 @default.
• W2950876717 cites W1507344465 @default.
• W2950876717 cites W1520768660 @default.
• W2950876717 cites W1764237044 @default.
• W2950876717 cites W196234574 @default.
• W2950876717 cites W1966665964 @default.
• W2950876717 cites W1989819994 @default.
• W2950876717 cites W2020146516 @default.
• W2950876717 cites W2026007418 @default.
• W2950876717 cites W2037294713 @default.
• W2950876717 cites W2037661198 @default.
• W2950876717 cites W2061187686 @default.
• W2950876717 cites W2065546702 @default.
• W2950876717 cites W2073946244 @default.
• W2950876717 cites W2090911342 @default.
• W2950876717 cites W2093809958 @default.
• W2950876717 cites W2106683058 @default.
• W2950876717 cites W2109182328 @default.
• W2950876717 cites W2122656606 @default.
• W2950876717 cites W2127775564 @default.
• W2950876717 cites W2146426990 @default.
• W2950876717 cites W2154849041 @default.
• W2950876717 cites W2285563028 @default.
• W2950876717 cites W2295355087 @default.
• W2950876717 cites W2316710655 @default.
• W2950876717 cites W2338490094 @default.
• W2950876717 cites W2394548811 @default.
• W2950876717 cites W2410578859 @default.
• W2950876717 cites W2521130261 @default.
• W2950876717 cites W2567785252 @default.
• W2950876717 cites W2596849336 @default.
• W2950876717 cites W2722788375 @default.
• W2950876717 cites W2748664071 @default.
• W2950876717 cites W2762679194 @default.
• W2950876717 cites W2766890505 @default.
• W2950876717 cites W2783949242 @default.
• W2950876717 cites W2805628514 @default.
• W2950876717 cites W2806169024 @default.
• W2950876717 cites W2806831508 @default.
• W2950876717 cites W2807406733 @default.
• W2950876717 cites W2809744609 @default.
• W2950876717 cites W2975677051 @default.
• W2950876717 cites W36895966 @default.
• W2950876717 doi "https://doi.org/10.1371/journal.pone.0217597" @default.
• W2950876717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6561568" @default.
• W2950876717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31188848" @default.
• W2950876717 hasPublicationYear "2019" @default.
• W2950876717 type Work @default.
• W2950876717 sameAs 2950876717 @default.
• W2950876717 citedByCount "20" @default.
• W2950876717 countsByYear W29508767172020 @default.
• W2950876717 countsByYear W29508767172021 @default.
• W2950876717 countsByYear W29508767172022 @default.
• W2950876717 countsByYear W29508767172023 @default.
• W2950876717 crossrefType "journal-article" @default.
• W2950876717 hasAuthorship W2950876717A5008945022 @default.
• W2950876717 hasAuthorship W2950876717A5034425770 @default.
• W2950876717 hasAuthorship W2950876717A5034880637 @default.
• W2950876717 hasAuthorship W2950876717A5042290811 @default.
• W2950876717 hasAuthorship W2950876717A5052727163 @default.
• W2950876717 hasAuthorship W2950876717A5068301606 @default.
• W2950876717 hasBestOaLocation W29508767171 @default.
• W2950876717 hasConcept C114851261 @default.
• W2950876717 hasConcept C126322002 @default.
• W2950876717 hasConcept C142724271 @default.
• W2950876717 hasConcept C144024400 @default.
• W2950876717 hasConcept C149923435 @default.
• W2950876717 hasConcept C151956035 @default.
• W2950876717 hasConcept C2775843808 @default.
• W2950876717 hasConcept C2776228421 @default.
• W2950876717 hasConcept C2776967927 @default.
• W2950876717 hasConcept C2778607973 @default.
• W2950876717 hasConcept C2780459521 @default.
• W2950876717 hasConcept C2781069245 @default.
• W2950876717 hasConcept C501593827 @default.
• W2950876717 hasConcept C71924100 @default.
• W2950876717 hasConcept C86803240 @default.
• W2950876717 hasConcept C89423630 @default.
• W2950876717 hasConceptScore W2950876717C114851261 @default.
• W2950876717 hasConceptScore W2950876717C126322002 @default.
• W2950876717 hasConceptScore W2950876717C142724271 @default.
• W2950876717 hasConceptScore W2950876717C144024400 @default.
• W2950876717 hasConceptScore W2950876717C149923435 @default.
• W2950876717 hasConceptScore W2950876717C151956035 @default.
• W2950876717 hasConceptScore W2950876717C2775843808 @default.
• W2950876717 hasConceptScore W2950876717C2776228421 @default.

• next